6NEA
Human Acetylcholinesterase in complex with reactivator, HLo7
6NEA の概要
エントリーDOI | 10.2210/pdb6nea/pdb |
分子名称 | Acetylcholinesterase, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... (6 entities in total) |
機能のキーワード | hydrolase |
由来する生物種 | Homo sapiens (Human) |
タンパク質・核酸の鎖数 | 2 |
化学式量合計 | 121746.94 |
構造登録者 | Bester, S.M.,McGuire, J.,Height, J.J.,Pegan, S.D. (登録日: 2018-12-17, 公開日: 2019-06-12, 最終更新日: 2024-10-23) |
主引用文献 | Hsu, F.L.,Bae, S.Y.,McGuire, J.,Anderson, D.R.,Bester, S.M.,Height, J.J.,Pegan, S.D.,Walz, A.J. Synthesis and Molecular Properties of Nerve Agent Reactivator HLo-7 Dimethanesulfonate. Acs Med.Chem.Lett., 10:761-766, 2019 Cited by PubMed Abstract: The threat of a deliberate release of chemical nerve agents has underscored the need to continually improve field effective treatments for these types of poisonings. The oxime containing HLö-7 is a potential second-generation therapeutic reactivator. A synthetic process for HLö-7 is detailed with improvements to the DIBAL reduction and ion exchange steps. HLö-7 was visualized for the first time within the active site of human acetylcholinesterase and its relative potency confirmed against various nerve agents using a phrenic nerve hemidiaphragm assay. PubMed: 31097996DOI: 10.1021/acsmedchemlett.9b00021 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.419 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード